Elkedonia strengthens Board of Directors with appointment of Pierre d’Epenoux as Independent Chairman

Elkedonia appoints industry veteran Pierre d’Epenoux, former CEO of ImCheck Therapeutics, as Independent Chairman to strengthen its Board of Directors. This leadership addition supports the company’s growth as it advances its innovative, non-hallucinogenic neuroplastogens targeting the ELK1 protein for major depressive disorder.